Reply to: Efficacy and pharmacodynamics of simulated human-like treatment with levofloxacin on experimental pneumonia induced with penicillin-resistant pneumococci with various susceptibilities to fluoroquinolones.
Rubinstein
Ethan
E
D000818:Animals; D000890:Anti-Infective Agents / Q000097:blood / Q000627:therapeutic use*; D004195:Disease Models, Animal; D064704:Levofloxacin; D015242:Ofloxacin / Q000097:blood / Q000627:therapeutic use*; D010403:Penicillin Resistance; D011018:Pneumonia, Pneumococcal / Q000188:drug therapy* / Q000382:microbiology; D015363:Quinolones / Q000494:pharmacology*; D011817:Rabbits; D013296:Streptococcus pneumoniae / Q000187:drug effects* / Q000235:genetics
D000890:Anti-Infective Agents; D015363:Quinolones; D064704:Levofloxacin; D015242:Ofloxacin